Formulation

Oct 23, 2017
By BioPharm International Editors
The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.
Oct 16, 2017
By BioPharm International Editors
Through the support of the Japanese agency, Daiichi Sankyo intends to further develop its genetic vaccine platform focused around its new nucleic acid delivery technology.
Oct 11, 2017
By BioPharm International Editors
Gelest, a manufacturer and provider of silane, silicone, and metal-organic compounds, released a range of dual-function poly(ethylene glycol) (PEG) reagents that enable new approaches to PEGylation for bioconjugates.
Oct 01, 2017
BioPharm International
There is a lot of interest in delivering biologics via non-invasive routes in attempt to improve patient compliance and convenience.
Sep 28, 2017
By BioPharm International Editors
Nemera is now authorized to handle, assemble, sterilize, and store pharmaceutical drugs and medicinal products for autoinjector combination products at its facility in Neuenburg, Germany.
Sep 21, 2017
By BioPharm International Editors
Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.
Sep 15, 2017
BioPharm International
This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Sep 15, 2017
BioPharm International
Consider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
Sep 15, 2017
BioPharm International
A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Sep 15, 2017
The authors review methods for generating monoclonal antibodies for research and development.
native1_300x100
lorem ipsum